SEC Form 4 · accession 0001209191-16-139793
Sarepta Therapeutics, Inc. · SRPT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jayant Aphale
Officer — SVP, Technical Operations
Period of report
Aug 31, 2016
Accepted (ET)
Sep 2, 2016 · 4:34 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000873303
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 31, 2016 | F | 765 | $26.07 | D | 11,490 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares withheld by the Company to satisfy tax withholding obligations related to the vesting of restricted stock granted to executive in lieu of a portion of the executive's annual cash bonus on February 29, 2016 and reported on the executive's Form 4 filed on March 2, 2016.